Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Isoray Inc (ISR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 26,421
  • Shares Outstanding, K 67,331
  • Annual Sales, $ 5,920 K
  • Annual Income, $ -6,700 K
  • 60-Month Beta 2.19
  • Price/Sales 4.43
  • Price/Cash Flow N/A
  • Price/Book 2.72
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.10
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/02/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.02
  • Number of Estimates 1
  • High Estimate -0.02
  • Low Estimate -0.02
  • Prior Year -0.02
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.36 +8.33%
on 03/27/19
0.41 -4.88%
on 04/15/19
+0.01 (+2.93%)
since 03/22/19
3-Month
0.34 +14.71%
on 02/19/19
0.46 -15.22%
on 02/13/19
unch (-0.51%)
since 01/23/19
52-Week
0.27 +44.98%
on 12/28/18
1.22 -68.03%
on 07/09/18
-0.05 (-10.34%)
since 04/23/18

Most Recent Stories

More News
IsoRay (ISR) Reports Q2 Loss, Tops Revenue Estimates

IsoRay (ISR) delivered earnings and revenue surprises of 0.00% and 8.43%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

ISR : 0.40 (+2.56%)
Isoray Announces Second Quarter Fiscal 2019 Financial Results

Record Revenue and Gross Profit

ISR : 0.40 (+2.56%)
IsoRay (ISR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

IsoRay (ISR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ISR : 0.40 (+2.56%)
Medical University of South Carolina Performs World's First Prostate Cancer Surgery Using Blu Build Brachytherapy System

- Isoray, Inc. (NYSE American: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced that Hollings Cancer Center...

ISR : 0.40 (+2.56%)
IsoRay, Inc. Discusses Competitive Landscape, FDA Clearance for New Product Line and Growth Drivers in New SNNLive Video Interview with StockNewsNow.com

LOS ANGELES, CA / ACCESSWIRE / May 17, 2018 / , The Official MicroCap News Source™, today published an SNNLive Video Interview with Tom LaVoy, Chairman of the Board & CEO of IsoRay, Inc. (NYSE American:...

ISR : 0.40 (+2.56%)
IsoRay Announces Participation at the American Urological Association's 2018 Annual Meeting, May 18-21, 2018

IsoRay, Inc. (NYSE American: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck and gynecological...

ISR : 0.40 (+2.56%)
IsoRay Announces Third Quarter Fiscal 2018 Revenue of $1.57 Million, 23% Third Quarter-Over-Third Quarter Increase

IsoRay, Inc. (NYSE American:ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck and gynecological...

ISR : 0.40 (+2.56%)
IsoRay to Present at the 3rd Annual Disruptive Growth & Healthcare Conference hosted by RHK Capital

IsoRay, Inc. (NYSE American: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck and gynecological...

ISR : 0.40 (+2.56%)
IsoRay Announces Third Quarter Fiscal 2018 Earnings Conference Call

IsoRay, Inc. (the "Company") (NYSE American: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head...

ISR : 0.40 (+2.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade ISR with:

Business Summary

IsoRay, Inc. is a medical technology company that produces therapeutic radioactive isotopes. Through its subsidiary, IsoRay Medical, Inc., develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. The Company is engaged in the...

See More

Key Turning Points

2nd Resistance Point 0.41
1st Resistance Point 0.40
Last Price 0.40
1st Support Level 0.38
2nd Support Level 0.37

See More

52-Week High 1.22
Fibonacci 61.8% 0.86
Fibonacci 50% 0.74
Fibonacci 38.2% 0.63
Last Price 0.40
52-Week Low 0.27

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar